IHM
CLSD

Iguana Healthcare Management’s Clearside Biomedical CLSD Stock Holding History

Iguana Healthcare Management’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-5,001
Closed -$526K – 85
2016
Q2 		$526K Buy
+5,001
New +$524K 0.21% 75

Other funds holding CLSD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Iguana Healthcare Management's CLSD Position: Q3 2016 in Review

Iguana Healthcare Management sold out of Clearside Biomedical (CLSD) in Q3 2016, closing a stake of 5,001 shares — an estimated $526K sold.

Iguana Healthcare Management first reported a position in CLSD in Q2 2016 and held it in 1 quarter. The position peaked at $526K in Q2 2016. 30 funds tracked by Wall St. Rank hold CLSD as of Q3 2016.

  • Iguana Healthcare Management reported no remaining Clearside Biomedical position as of Q3 2016 after selling out during the quarter.
  • Iguana Healthcare Management sold 5,001 Clearside Biomedical shares in Q3 2016, an estimated $526K.
  • Iguana Healthcare Management first reported a position in Clearside Biomedical in Q2 2016 and held it in 1 quarter.
  • Iguana Healthcare Management's Clearside Biomedical position peaked at $526K in Q2 2016.
  • 30 funds tracked by Wall St. Rank held Clearside Biomedical as of Q3 2016.

Based on Iguana Healthcare Management's 13F filing for Q3 2016, filed 14 Nov 2016.